Analystreport

Adaptimmune Therapeutics plc (NASDAQ: ADAP) had its price target raised by analysts at SVB Leerink LLC from $5.00 to $6.00. They now have a "market perform" rating

Adaptimmune Therapeutics plc - American Depositary Shares  (ADAP) 
Last adaptimmune therapeutics plc - american depositary shares earnings: 5/9 07:30 am Check Earnings Report